NPHC : Summary for NUTRA PHARMA CORP USD0.001(POST - Yahoo Finance

U.S. Markets closed

Nutra Pharma Corp. (NPHC)


Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.01+0.00 (+12.35%)
At close: 3:29PM EST
People also watch
MCETAMARHDVYSNGXQMDT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close0.01
Open0.01
Bid0.00 x
Ask0.00 x
Day's Range0.01 - 0.01
52 Week Range0.01 - 0.02
Volume988,000
Avg. Volume1,359,738
Market Cap2.32M
Beta-0.17
PE Ratio (TTM)-0.65
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Marketwired25 days ago

    Nutra Pharma Letter to Shareholders

    Nutra Pharma Corporation , a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter pain management market, and which is also developing treatments for Multiple Sclerosis , ...

  • Nutra Pharma Corp. :NPHC-US: Earnings Analysis: Q3, 2016 By the Numbers : November 29, 2016
    Capital Cube2 months ago

    Nutra Pharma Corp. :NPHC-US: Earnings Analysis: Q3, 2016 By the Numbers : November 29, 2016

    Categories: Yahoo Finance Get free summary analysis Nutra Pharma Corp. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of Nutra Pharma Corp. – Sangamo BioSciences, Inc., Albany Molecular Research, Inc., USANA Health Sciences, Inc. and Natural Alternatives International, Inc. (SGMO-US, AMRI-US, USNA-US and NAII-US) that have also ... Read more (Read more...)

  • Marketwiredlast year

    Nutra Pharma Letter to Shareholders

    Nutra Pharma Corporation , a biotechnology company marketing Nyloxin® and Pet Pain-Away in the over-the-counter pain management market, and which is also developing treatments for Multiple Sclerosis , ...